RxDoctor Payments Data

Paul Pagano, MD

Orthopaedic Surgery of the Spine · St Petersburg, FLNPI 1215930912

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $124,999 of the $163,557 with a category attached, or 76.4%. Kalitec Direct LLC accounts for 98.3% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2020 at $48,909 and has fallen 91.6% since, to $4,085 in 2025.

$163,557in general payments, 2019–2025

Across 71 payments — averaging $2303.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kalitec Direct LLC$161K
  • Spinal Elements, Inc.$1K
  • Medtronic$342
  • Si-bone, Inc.$229
  • Innovation Technologies Inc$169
  • Choice Spine, LLC$148
  • plus $886 from 17 others
$62,293in ownership & investment interests, 2019–2025

Across 7 payments — averaging $8899.00 each. An ownership or investment interest held by the physician or an immediate family member.

  • Kalitec Direct LLC$62K

What the payments were for

  • Royalty or licence$35,60422%
  • Food & beverage$2,9542%
  • Ownership interest$124,99976%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$163,557 in reported general payments places this provider in the 75th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$291,855
Medicare patients
401
Services billed
4,030

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl217$1,859
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen150$1,625
Methylprednisolone89$648
Gabapentin58$542
Celecoxib18$483
Cyclobenzaprine Hcl41$401
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen45$332
Tramadol Hcl98$326
Baclofen40$255
Mupirocin19$154
Pregabalin13$95
Oxycodone Hcl11$52
Diazepam15$20
Meloxicam13$18

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →